Atlas Lithium Corporation (ATLX)
NASDAQ: ATLX · Real-Time Price · USD
4.340
-0.220 (-4.82%)
At close: Aug 1, 2025, 4:00 PM
4.420
+0.080 (1.84%)
After-hours: Aug 1, 2025, 6:46 PM EDT
Verve Therapeutics Stock Forecast
ATLX's stock price has decreased by -61.25% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts that cover Verve Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $22.25, which forecasts a 412.67% increase in the stock price over the next year. The lowest target is $19 and the highest is $25.5.
Price Target: $22.25 (+412.67%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 29, 2024.
Analyst Ratings
The average analyst rating for Verve Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +337.79% | Oct 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $41 → $19 | Strong Buy | Maintains | $41 → $19 | +337.79% | Oct 3, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $36 → $26 | Strong Buy | Maintains | $36 → $26 | +487.56% | Jul 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $41 | Strong Buy | Maintains | $40 → $41 | +844.70% | Jul 9, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $75 → $55 | Strong Buy | Maintains | $75 → $55 | +1,167.28% | Apr 2, 2024 |
Financial Forecast
Revenue This Year
148.00M
from 748.65K
Increased by 19,668.81%
Revenue Next Year
211.86M
from 148.00M
Increased by 43.15%
EPS This Year
0.19
from -2.91
EPS Next Year
n/a
from 0.19
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 152.4M | 218.1M | 545.2M |
| Avg | 148.0M | 211.9M | 529.7M |
| Low | 142.2M | 203.6M | 508.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 20,251.2% | 47.4% | 157.4% |
| Avg | 19,668.8% | 43.1% | 150.0% |
| Low | 18,894.1% | 37.5% | 140.2% |
EPS Forecast
| EPS | 2025 |
|---|---|
| High | 3.11 |
| Avg | 0.19 |
| Low | -2.53 |
EPS Growth
| EPS Growth | 2025 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.